These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 2476522
1. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining. Katoch VM, Katoch K, Ramanathan U, Sharma VD, Shivannavar CT, Datta AK, Bharadwaj VP. Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):615-21. PubMed ID: 2476522 [Abstract] [Full Text] [Related]
2. In vitro methods for determination of viability of mycobacteria: comparison of ATP content, morphological index and FDA-EB fluorescent staining in Mycobacterium leprae. Katoch VM, Katoch K, Ramu G, Sharma VD, Datta AK, Shivannavar CT, Desikan KV. Lepr Rev; 1988 Jun; 59(2):137-43. PubMed ID: 2469924 [No Abstract] [Full Text] [Related]
3. Incidence of late lepra reaction among multibacillary leprosy patients after MDT. Vijayakumaran P, Manimozhi N, Jesudasan K. Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714 [Abstract] [Full Text] [Related]
4. Assessing the viability of Mycobacterium leprae by the fluorescein diacetate/ethidium bromide staining technique. Palomino JC, Falconi E, Marin D, Guerra H. Indian J Lepr; 1991 Mar; 63(2):203-8. PubMed ID: 1723741 [Abstract] [Full Text] [Related]
5. Staining tissue-derived Mycobacterium leprae with fluorescein diacetate and ethidium bromide. Kvach JT, Munguia G, Strand SH. Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):176-82. PubMed ID: 6202650 [Abstract] [Full Text] [Related]
6. Histopathologic observations on the persistence of Mycobacterium leprae in the skin of multibacillary leprosy patients under chemotherapy. Wabitsch KR, Meyers WM. Lepr Rev; 1988 Dec; 59(4):341-6. PubMed ID: 2468983 [No Abstract] [Full Text] [Related]
11. Comparison of radiometric macrophage assay and fluorescein diacetate/ethidium bromide staining for evaluation of M. leprae viability. Harshan KV, Prasad HK, Chopra NK, Mishra RS, Gogiya P, Nath I. Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):316-21. PubMed ID: 2439621 [Abstract] [Full Text] [Related]
12. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy. Katoch K, Katoch VM, Natrajan M, Bhatia AS, Sreevatsa, Gupta UD, Sharma VD, Shivannavar CT, Patil MA, Bharadwaj VP. Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215 [Abstract] [Full Text] [Related]
13. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy. Naik SS, Bhanage ND, Sawant KV, Ganapati R. Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827 [Abstract] [Full Text] [Related]
18. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy. Narang T, Kaur I, Kumar B, Radotra BD, Dogra S. Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653 [Abstract] [Full Text] [Related]
20. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy. Sivaprasad N, Snehalatha S, Lobo D, Aschhoff M, Job CK. Indian J Lepr; 1995 Jun; 67(4):427-33. PubMed ID: 8849919 [Abstract] [Full Text] [Related] Page: [Next] [New Search]